| Biological Sciences | Lifetime | 16 | CA 1 | 100.00 |
| Biological Sciences | 2021-2025 | 936 | CA 23 | 98.97 |
| Microbiology | Lifetime | 1 | CA 1 | 99.99 |
| Molecular Biology | Lifetime | 90 | CA 3 | 99.96 |
| Genetics | Lifetime | 114 | CA 8 | 99.77 |
| Molecular Medicine | Lifetime | 9 | CA 1 | 99.81 |
| Immunology | Lifetime | 334 | CA 9 | 99.18 |
| Ecology | Lifetime | 751 | CA 51 | 98.19 |
| Clinical Pharmacology | Lifetime | 567 | CA 41 | 97.55 |
| Infectious Diseases | Lifetime | 903 | CA 29 | 95.56 |
| Endocrinology | Lifetime | 358 | CA 20 | 92.89 |
| Applied Microbiology and Biotechnology | Lifetime | 227 | CA 12 | 82.59 |
| Microbiology | 2021-2025 | 17 | CA 1 | 98.21 |
| Molecular Biology | 2021-2025 | 926 | CA 18 | 94.76 |
| Antimicrobial Peptides and Activities | Lifetime | 1 | CA 1 | 99.99 |
| Bacterial biofilms and quorum sensing | Lifetime | 1 | CA 1 | 99.97 |
| Bacterial Genetics and Biotechnology | Lifetime | 2 | CA 1 | 99.95 |
| Antibiotic Resistance in Bacteria | Lifetime | 5 | CA 1 | 99.97 |
| Bacteriophages and microbial interactions | Lifetime | 8 | CA 1 | 99.91 |
| Biochemical and Structural Characterization | Lifetime | 2 | CA 1 | 99.97 |
| Immune Response and Inflammation | Lifetime | 14 | CA 1 | 99.95 |
| Lipid Membrane Structure and Behavior | Lifetime | 21 | CA 3 | 99.77 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 43 | CA 3 | 99.69 |
| Antimicrobial agents and applications | Lifetime | 9 | CA 1 | 99.39 |
| Pediatric health and respiratory diseases | Lifetime | 31 | CA 2 | 99.66 |
| Aquaculture disease management and microbiota | Lifetime | 98 | CA 4 | 99.29 |
| Vibrio bacteria research studies | Lifetime | 63 | CA 3 | 99.33 |
| RNA and protein synthesis mechanisms | Lifetime | 250 | CA 7 | 99.38 |
| Invertebrate Immune Response Mechanisms | Lifetime | 50 | CA 1 | 99.03 |
| Chemical Synthesis and Analysis | Lifetime | 273 | CA 9 | 99.27 |
| vaccines and immunoinformatics approaches | Lifetime | 68 | CA 1 | 99.00 |
| Polydiacetylene-based materials and applications | Lifetime | 36 | CA 1 | 98.74 |
| Protein Hydrolysis and Bioactive Peptides | Lifetime | 208 | CA 12 | 98.47 |
| Probiotics and Fermented Foods | Lifetime | 327 | CA 19 | 98.52 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 294 | CA 11 | 98.58 |
| Cystic Fibrosis Research Advances | Lifetime | 216 | CA 28 | 98.02 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 428 | CA 23 | 96.97 |
| Nanopore and Nanochannel Transport Studies | Lifetime | 312 | CA 10 | 96.16 |
| Bioinformatics and Genomic Networks | Lifetime | 623 | CA 29 | 95.90 |
| Antibiotic Use and Resistance | Lifetime | 547 | CA 25 | 96.74 |
| Oral microbiology and periodontitis research | Lifetime | 968 | CA 31 | 96.54 |
| Inhalation and Respiratory Drug Delivery | Lifetime | 935 | CA 65 | 94.63 |
| Historical Medical Research and Treatments | Lifetime | 62 | CA 1 | 92.58 |
| Immune responses and vaccinations | Lifetime | 554 | CA 20 | 86.93 |
| Infections and bacterial resistance | Lifetime | 769 | CA 37 | 77.85 |
| Antimicrobial Peptides and Activities | 2021-2025 | 8 | CA 1 | 98.74 |
| Bacterial biofilms and quorum sensing | 2021-2025 | 17 | CA 1 | 98.55 |
| Antibiotic Resistance in Bacteria | 2021-2025 | 606 | CA 11 | 93.97 |
| Immune Response and Inflammation | 2021-2025 | 259 | CA 7 | 88.15 |
| Biochemical and Structural Characterization | 2021-2025 | 95 | CA 1 | 88.48 |
| Immune responses and vaccinations | 2021-2025 | 385 | CA 19 | 72.56 |
| Antimicrobial agents and applications | 2021-2025 | 551 | CA 10 | 69.25 |
